Systematic review of factors influencing patient and practitioner delay in diagnosis of upper gastrointestinal cancer by Campbell, N.C. et al.
Systematic review of factors influencing patient and practitioner
delay in diagnosis of upper gastrointestinal cancer
S Macdonald1, U Macleod1, NC Campbell2, D Weller3 and E Mitchell*,4
1General Practice and Primary Care, Division of Community Based Sciences, University of Glasgow, 1 Horselethill Road, Glasgow G12 9LX, UK; 2General
Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen AB25 2AY, UK; 3Community Health Sciences
(General Practice), University of Edinburgh, 20 West Richmond Street, Edinburgh EH8 9DX, UK; 4School of Health and Social Care, Glasgow Caledonian
University, City Campus, Cowcaddens Road, Glasgow G4 0BA, UK
As knowledge on the causation of cancers advances and new treatments are developed, early recognition and accurate diagnosis
becomes increasingly important. This review focused on identifying factors influencing patient and primary care practitioner delay for
upper gastrointestinal cancer. A systematic methodology was applied, including extensive searches of the literature published from
1970 to 2003, systematic data extraction, quality assessment and narrative data synthesis. Included studies were those evaluating
factors associated with the time interval between a patient first noticing a cancer symptom and presenting to primary care, between a
patient first presenting to primary care and being referred to secondary care, or describing an intervention designed to reduce those
intervals. Twenty-five studies were included in the review. Studies reporting delay intervals demonstrated that the patient phase of
delay was greater than the practitioner phase, whilst patient-related research suggests that recognition of symptom seriousness is
more important than recognition of the presence of the symptom. The main factors related to practitioner delay were misdiagnosis,
application and interpretation of tests, and the confounding effect of existing disease. Greater understanding of patient factors is
required, along with evaluation of interventions to ensure appropriate diagnosis, examination and investigation.
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Achieving a reduction in deaths from cancer is a worldwide health-
care priority. As new knowledge on the causation of cancers is
discovered, new treatments developed and the search for cures
continues, early recognition and accurate diagnosis becomes
increasingly important. This is particularly relevant in the context
of primary care, where many patients present with symptoms
suggestive of cancer, but where the outcome of the diagnostic
process is the exclusion of cancer in the majority of cases.
Detecting and diagnosing cancer when it is at an early stage
improves prognosis for many cancers (Love, 1991; Ponten et al,
1995; Richards et al, 1999; Summerton, 1999). Previous work on
delay has shown that this can occur at three phases in the time
from initial symptom to diagnosis. Firstly, there is the interval
between first noticing a symptom and first consulting a doctor
(patient delay); secondly, the interval between first consultation
with a doctor and referral (practitioner delay); and finally, the time
between referral and diagnosis (hospital delay) (Nichols et al,
1981). If a reduction in deaths from cancer is to be achieved, a
greater understanding of the reasons for late and delayed diagnosis
in patients with potential cancer symptoms is required. This is a
significant challenge, especially for primary care, which is usually
the patient’s first contact with the health services and conse-
quently, the area to which the first two phases of delay are
particularly applicable.
We conducted a systematic review of the factors that influence
patient and practitioner delay (Macdonald et al, 2004) for all adult
cancers for which the UK Department of Health (DoH) has
published referral guidelines, with the exception of breast cancer
(Department of Health, 2000; National Institute for Health and
Clinical Excellence, 2005). This paper outlines the methods used in
the review and presents results for upper gastrointestinal (GI)
cancers.
MATERIALS AND METHODS
A worldwide review of the literature from 1970 to November 2003
was conducted. Extensive searches of Medline, EMBASE, CINAHL,
PsycINFO, ISI Science Citation Index, ISI Social Sciences Citation
Index and the International Bibliography of the Social Sciences
were carried out. Supplementary searches of Proceedings First and
Web of Science Proceedings were conducted to provide relevant
unpublished research. The Effective Practice and Organisation
of Care, Consumers and Communication and cancer-related
Cochrane Collaborative Review Groups were asked for details of
any potentially relevant studies. The National Research Register
and the DoH Research Findings electronic Register (ReFeR) were
accessed online for details of ongoing or recently completed
projects, and the Medical Research Council, Cancer Research UK
and the Chief Scientist Office of the Scottish Executive Health
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Department were contacted for details of relevant work. A database
of almost 300 UK contacts with a particular interest in cancer was
established, representing Scottish and English health authorities,
cancer networks and cancer leads. A list of international contacts
was also compiled, including similar organisations in North
America, Europe, Australia and New Zealand. Requests were made
to authors active in the field for studies-in-progress and
unpublished work. Citations in literature reviews and articles
obtained were also reviewed, as were references provided by
colleagues.
Study selection
Studies in any language and of any design were considered. Studies
were selected if they focused on adult cancer and (a) the
participants were individuals/groups of patients or primary care
practitioners and (b) they evaluated factors associated with the
time interval between a patient first noticing a cancer symptom
and first presenting to a primary health-care provider, or
described an intervention designed to reduce that interval or (c)
they evaluated factors associated with the time interval between the
patient first presenting to primary care and being referred to
secondary care, or described an intervention designed to reduce
that interval. We were also interested in identifying the factors
associated with patient and provider behaviour, in relation to their
impact on patient help-seeking or on practitioner referral, and
studies that determined provider attitudes or behaviour towards
referral of patients with cancer were also included, as were those
that determined patient attitudes towards cancer awareness and
presentation behaviour. Studies evaluating delay from presentation
to treatment were not excluded until they had been reviewed to
ensure that they did not differentiate between possible stages
within the delay cycle. Studies that simply assessed the outcome of
delay in terms of diagnosis, treatment or patient outcomes were
excluded, as were those assessing costs of interventions or validity
of referral decisions.
All references identified were independently assessed by two
reviewers (SM, UM). Abstracts were reviewed and full texts of
studies not excluded at this stage were retrieved for detailed
evaluation. Discrepancies were independently validated by a third
reviewer (EM). All potentially relevant studies were independently
read and, if included in the review, independently rated by the
same two reviewers. Where differences of opinion occurred, papers
were read by the third reviewer and findings discussed until a
consensus was reached.
Strength of evidence
Methodological quality of experimental studies (randomised
controlled trial, clinical trials, controlled before and after studies)
was assessed for sample formation, baseline differences between
groups, unit of allocation to groups, measures of outcome and
follow-up (Appendix A1). Owing to the lack of controlled trials in
this field, a method of scoring descriptive studies (cross-sectional,
cohort, case–control, before and after studies) was also used,
allowing interpretation of useful papers that would be discarded by
strict adherence to Cochrane standards. Each study was scored on
six criteria relevant to its design (e.g. case–control was assessed
for a clear research question, source of cases/controls, clear
inclusion/exclusion criteria, sampling method and comparability
of the groups) (Appendix B1). Similar use of these systems has
been described elsewhere (Mitchell and Sullivan, 2001).
However, many papers in this review used methodologies that
did not lend themselves to the scoring systems outlined. Several
included every patient attending a particular clinic and most
collected data using either medical records review or structured
interviews with patients. We therefore assessed each included
study for the strength of its evidence in relation to the factors
reported as leading to increased or decreased delay. Assessment of
studies that had already been rated using the systems outlined
above was based on those previous scores. Evidence was rated as
‘strong’ if a paper had an adequate sample size, used a rigorous
methodology to ascertain data (i.e. not open to selection bias)
and reported statistically significant differences in relation to the
factors identified (or used appropriate analytic techniques if
qualitative). Evidence was rated as ‘moderate’ if a paper had an
adequate sample size, reported significant differences but used a
less rigorous methodology to ascertain data, or had an adequate
sample size, used a rigorous methodology to ascertain data but
used comparative analysis or reported only relevant descriptive
statistics, without performing statistical testing of differences.
Finally, evidence was rated as ‘insufficient’ if a paper had an
unclear or inappropriate method of ascertaining data and
insufficient analysis. If a study inferred results, the strength of
its evidence was reduced, for example, strong became moderate.
Narrative synthesis of findings was then carried out to identify
key concepts and themes that were shared across individual
studies. Textual information on cancer group, delay aspects
studied and differences resulting from any intervention was also
recorded.
RESULTS
The search strategy identified 6441 abstracts, which were reviewed
to determine their suitability for inclusion (Figure 1). Full reprints
were obtained for the 104 articles that met the inclusion criteria
and these were evaluated further. Kappa co-efficient for inter-rater
agreement beyond chance was 0.5. Twenty-five papers were
included in the review.
The majority of included studies (n¼ 18) were conducted in
western Europe, almost half of these in the UK. None of the studies
employed a controlled trial methodology. Most involved medical
records review and/or structured interviews with patients; seven
studies used mixed methods of data collection. More than half of
the papers studied patient and practitioner delay factors, six
studied patient factors only and six studied practitioner factors
only. Prominence was given to stomach, followed by oesophagus,
pancreas and small intestine. Nine papers were assessed as
Studies included in the 
systematic review (n=25) * 
Potentially relevant articles identified 
and screened for retrieval (n=6441)  
Studies retrieved for 
detailed evaluation (n=104) 
Studies excluded following 
review of abstract (n=6337) 
Studies excluded: 
no delay factors (n=33); descriptive
only (n=25); review (n=7); hospital 
delay only (n=6); unable to locate/
translate (n=5); no distinction between
phases (n=2); screening (n=1) 
* n=25 – five papers related to more than one cancer group
Figure 1 Flow of studies into the review.
Delay in diagnosis of upper GI cancers
S Macdonald et al
1273
British Journal of Cancer (2006) 94(9), 1272 – 1280& 2006 Cancer Research UK
C
li
n
ic
a
l
S
tu
d
ie
s
providing strong evidence, nine provided moderate evidence and
seven provided insufficient evidence.
In general, studies were relatively small in size, involving
between 30 and 2500 participants (mean 383; median 133).
Only two of the studies included practitioners as participants.
In the majority, the population under study was identified
from secondary care (n¼ 21). In seven studies participants were
hospital in-patients, in four they were outpatient attenders and in
two others both in-patients and outpatients were involved. A
further seven studies identified patients from hospital records. One
study involved members of the public, and another patients
participating in an existing trial. Only three studies recruited
from primary care. The period under study ranged from 1 week to
30 years.
Delay intervals
Twenty studies reported length of delay, either from patient
recognition of symptoms to first presentation (n¼ 17) or from
presentation to referral or diagnosis (n¼ 13). Median patient delay
ranged from 2 weeks to 7.5 months (Bedikan et al, 1979; Mikulin
and Hardcastle, 1987; Zilling et al, 1990; Haugstvedt et al, 1991;
Wile et al, 1993; Porta et al, 1996; Martin et al, 1997; Mariscal et al,
2001; Irving et al, 2002; Look et al, 2003) and practitioner delay
from zero to just under 9 months (Mikulin and Hardcastle, 1987;
Zilling et al, 1990; Haugstvedt et al, 1991; Jones and Dudgeon,
1992; Martin et al, 1997; Mariscal et al, 2001; Irving et al, 2002;
Look et al, 2003).
Factors influencing patient delay
Nineteen papers considered factors that influenced patient delay in
presentation. Thirteen identified factors that increased delay and
13 identified factors that decreased delay (Table 1).
Symptoms, patient’s interpretation of them and the associated
impact on delay emerged as a major theme across studies.
Heightened awareness of symptoms provoked more prompt
presentation to a practitioner (Ojala et al, 1982; Delaney, 1998;
Gullo et al, 2001), whereas lack of awareness resulted in delay
(Nagao and Takahashi, 1979; Mikulin and Hardcastle, 1987;
Arvanitakis et al, 1992; Porta et al, 1996; Rothwell et al, 1997;
Ibingira, 2001). Similarly, the perceived significance of symptoms
was a key factor, but the precise nature of its effect on delay was
inconclusive. Many patients consulted more quickly when their
symptoms were more serious or were perceived to be more
serious, including the presence of pain or bleeding (Hackett et al,
1973; MacAdam, 1979; Ojala et al, 1982; Mikulin and Hardcastle,
1987; Maglinte et al, 1991; Grannell et al, 2001; Mariscal et al,
2001). For others, however, experiencing pain increased their delay
(Hackett et al, 1973; Ibingira, 2001; Look et al, 2003), as did
weight loss (Haugstvedt et al, 1991). The presence of multiple
symptoms or comorbidity resulted in more prompt presentation
(Porta et al, 1996; Mariscal et al, 2001).
The fear associated with recognising potential cancer symptoms
was found to have both a positive (Delaney, 1998) and negative
(Hackett et al, 1973) impact on presentation behaviour. Although
the associated worry could be beneficial in reducing delay, we also
found evidence that patients were less likely to consult when they
were afraid that their symptoms were indicative of cancer (Mikulin
and Hardcastle, 1987) or meant that they would have to undergo
tests (Delaney, 1998). Patients who redefined their symptoms,
perhaps in response to that fear, delayed longer (Delaney, 1998).
There was some evidence to suggest that the setting of first
presentation impacts on delay, with those who presented first to
hospital doing so after shorter symptom duration (Wile et al, 1993;
Mariscal et al, 2001) (Table 2).
A number of studies considered the relationship between certain
patient characteristics and presentation behaviour. Ethnicity was
Table 1 Main delay factors and assessment of evidence
No. of studies
(subjects) Supported (studies)
Not supported
(studies) No impact (studies)
Overall assessment
/conclusion
Increases patient delay
Non-recognition of symptom
seriousness
9 (1840) 2S, 3M, 4I — — Increases delay
Cancer site – stomach 2 (713) 1S, 1M — — Increases delay
Lower socio-economic status 4 (979) 2S, 1M — 1M Increases delay
Comorbidity 2 (400) — 2S — Reduces delay
First presenting to hospital 2 (266) — 2S — Reduces delay
Male sex 5 (797) 1I 1S 1S, 2M No impact on delay
Fear 3 (1271)a 2S, 1M 2S — Inconclusive
Experiencing pain 7 (1169) 1S, 1M, 1I 1S, 3M — Inconclusive
Older age 7 (800) 1S, 1M 1S, 2M 1S, 1M Inconclusive
Lower education 2 (400) 1S 1S — Inconclusive
Family history 3 (777) 1S 1S 1S Inconclusive
Increases practitioner delay
Initial misdiagnosis 6 (3556) 2M, 4I — — Increases delay
Acid suppression treatment 3 (316) 1S, 2M — — Increases delay
Inappropriate/inaccurate tests 3 (226) 1S, 2M — — Increases delay
Previous negative test result 2 (94) 1S, 1M — — Increases delay
Cancer site – oesophagus 2 (1580) 1M, 1I — — Increases delay
Female patient 2 (1215) 1S, 1M — — Increases delay
Older patient age 1 (83) — 1M — Reduces delay
Lower patient socio-economic status 1 (83) — 1M — Reduces delay
Use of referral guidelines 1 (90) — 1S — Reduces delay
Frequent patient attendance 2 (265) 1I — 1M Inconclusive
Comorbidity 2 (267) 1S 1S — Inconclusive
Use of rapid access endoscopy 2 (821) 1S 1I — Inconclusive
aPaper reports conflicting evidence (i.e. which both supports and refutes the factor as a cause of delay). S¼ strong evidence; M¼moderate evidence; I¼ insufficient evidence
(based on the methodological adequacy of the study).
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Table 2 Patient-associated delay factors
Author(s) Location Study type Participants Cancer site
Factors that increase
delay
Factors that decrease
delay
No impact on
delay
Strength of
evidence
Hackett et al (1973) Massachusetts,
USA
Prospective
observational
563 patients (aged 17 – 91;
mean 62; 46% men,
54% women),
6% with stomach cancer
Stomach Symptom type – pain;
cancer site – stomach;
social class – lower; worry
over health; family history
Worry; incapacitated by
symptoms;
acknowledgment of cancer
Strong
Bedikan et al (1979) Texas, USA Retrospective
observational
73 patients (aged o40;
48% men, 52% women)
Stomach Age – older Moderate
Nagao and Takahashi
(1979)
Japan Retrospective
observational
536 patients Stomach Non-recognition of
symptom seriousnessa
Insufficient
MacAdam (1979) England Prospective
observational
150 patients (21% with
stomach cancer),
105 GPs
Stomach Cancer site – stomach Symptom type –
abdominal pain, bleeding
Socio-economic
status; age; sex;
social isolation;
frequency of
consulting
Moderate
Ojala et al (1982) Finland Retrospective
observational
162 patients (aged
38 – 82, mean 63;
59% men, 41% women)
Oesophagus Patient awareness;
symptom type –
dysphagiaa
Insufficient
Mikulin and Hardcastle
(1987)
England Prospective
observational
83 patients (mean 71;
64% men, 36% women)
Stomach Non-recognition of
symptom seriousness;
symptom type – no pain;
fear; age – older; social
class – lower
Age – younger Sex Moderate
Zilling et al (1990) Sweden Prospective
observational
50 patients (aged 31 – 85,
mean 68; 74% men,
26% women)
Stomach Age – younger Strong
Haugstvedt et al
(1991)
Norway Prospective
observational
1165 patients Stomach Symptom type – weight
loss
Referral to university
hospital
Moderate
Maglinte et al (1991) Indiana, USA Retrospective
observational
77 patients (aged 30 – 89,
mean 59; 64% men,
36% women
Small
intestine
Symptom type – pain,
bleeding
Moderate
Arvanitakis et al
(1992)
Greece Observational 100 patients (aged
40 – 90; 64% men,
36% women)
Stomach Non-recognition of
symptom seriousness
Insufficient
Wile et al (1993) California,
USA
Retrospective
observational
49 patients (median 57;
45% men, 55% women)
Stomach First presenting at hospital;
ethnicity – minority groups
Strong
Porta et al (1996) Spain Prospective
observational
183 patients (mean 67;
66% men, 34% women)
Oesophagus,
stomach,
duodenum
Age – older; sex – male;
illiteracy; social class –
lower; unemployment;
non-recognition of
symptom seriousness
Age – younger;
comorbidity; recognition of
symptom seriousness
Marital status;
family history
Strong
Rothwell et al (1997) Ireland Prospective
observational
100 patients (aged 37 – 83,
median 69; 70% men,
30% women)
Oesophagus Non-recognition of
symptom seriousness
Moderate
Delaney (1998) England Qualitative
interviews
31 patients with dyspepsia
(aged 50+, mean 64;
52% men, 48% women)
Stomach Fear of investigation;
symptom re-definition;
fatalism
Recognition of symptom
seriousness; personal or
family history; fear of
cancer
Strong
Mariscal et al (2001) Spain Prospective
observational
217 patients (aged 59 – 74,
mean 65; 59% men,
41% women), 27% with
upper GI cancer
Oesophagus,
stomach
Education level – higher Comorbidity; symptom
type – pain, bleeding; first
presenting at hospital;
multiple symptoms
Age; sex;
availability of
vehicle
Strong
Gullo et al (2001) Italy Case – control 305 patients (aged 30 – 75,
mean 61; 62% men,
38% women) and 305
matched controls
Pancreas Symptom recognitiona Moderate
Ibingira (2001) Uganda Prospective
observational
35 patients (aged 34 – 78;
77% men, 23% women)
Stomach Non-recognition of
symptom seriousness;
symptom type – pain; acid
suppression treatment
Insufficient
Grannell et al (2001) Ireland Cross-sectional 164 members of the public
(93 aged o45, 71 aged
45+; 51% men,
49% women)
Oesophagus Sex – female Increased awareness –
dysphagiaa
Insufficient
Look et al (2003) Singapore Retrospective
observational
44 patients (aged 36 – 83,
mean 67; 70% men,
30% women)
Stomach Age – younger; symptom
type – pain
Moderate
Abbreviation: GI¼ gastrointestinal. aStudy infers findings.
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associated with reduced delay (Wile et al, 1993), while lower socio-
economic status (Hackett et al, 1973; Mikulin and Hardcastle,
1987; Porta et al, 1996) was associated with increased delay. By and
large, sex had no impact on delay (MacAdam, 1979; Mikulin and
Hardcastle, 1987; Porta et al, 1996; Mariscal et al, 2001), whereas
the evidence presented for education level (Porta et al, 1996;
Mariscal et al, 2001) and age was inconclusive (Bedikan et al, 1979;
MacAdam, 1979; Mikulin and Hardcastle, 1987; Zilling et al, 1990;
Porta et al, 1996; Mariscal et al, 2001; Look et al, 2003) (Table 2).
Factors influencing practitioner delay
Nineteen studies considered factors that influenced practitioner
delay in referral. Seventeen identified factors that increased delay
and six identified factors that decreased delay (Table 1).
Delay in referral was primarily related to initial misdiagnosis of
a common symptom or failure to make a diagnosis at the initial
encounter with the patient (Bedikan et al, 1979; Nagao and
Takahashi, 1979; Ojala et al, 1982; Hallissey et al, 1990; Arvanitakis
et al, 1992; Rothwell et al, 1997). Moreover, referral was likely to be
delayed if the patient was being treated for a benign condition,
particularly with acid suppression (Mikulin and Hardcastle, 1987;
Rothwell et al, 1997; Bramble et al, 2000). Inappropriate
application of tests, inaccurate test results and previous receipt
of negative test results were additional causes of delay (Zilling et al,
1990; Maglinte et al, 1991; Wile et al, 1993; Rothwell et al, 1997;
Look et al, 2003) (Table 3).
Some of the more recent studies evaluated policy initiatives
aimed at tackling referral delays. Where a rapid access endoscopy
service was available, patients were found to experience less delay
in referral (Martin et al, 1997; Manes et al, 2002), albeit with the
caveat that inappropriate use of such a service could actually
contribute to delay (Manes et al, 2002). Similarly, the introduction
of the DoH cancer referral guidelines was found to reduce delay
(Irving et al, 2002).
Evaluation of the impact of tumour site on delay demonstrated
that patients with oesophageal cancer were more likely to
experience delayed referral than patients with stomach cancer
(Martin et al, 1997). In addition, patients with any upper GI
cancer, regardless of site, were delayed more than patients
with colorectal or other cancers (MacAdam, 1979; Jones and
Dudgeon, 1992).
Only a limited number of patient characteristics were considered
in relation to practitioner delay. Male patients (Zilling et al, 1990;
Haugstvedt et al, 1991), older patients (Mikulin and Hardcastle,
1987) and patients from lower socio-economic groups (Mikulin
and Hardcastle, 1987) were less likely to experience delayed
referral (Table 3).
DISCUSSION
In 1938, the American Journal of Cancer published a paper by Pack
and Gallo (1938) entitled ‘The culpability for delay in the treatment
of cancer’. This was one of the first papers to study delay as it has
been considered in this review. Sadly, almost 70 years later, we
echo their findings. Analysis of the studies included in this review
shows that there are associations between at least 14 different
factors and delay. Five of these concerned delay by patients; nine
concerned delay by practitioners. The main themes to emerge
related to recognition and interpretation of symptoms, patient
history, patient characteristics and health-care factors.
Quality of studies
This was an extensive and comprehensive review of the world
literature; yet, although we identified an abundance of descriptive
work, few evaluative studies have been carried out. Great variation
in study design and quality precluded a meta-analysis; rather, we
graded study evidence by the robustness of its methodology and
analysis, allowing us to weight each study appropriately in our
overall assessment of delay-related factors. Any critique of this
type can only be based on the information that has been reported
and in many cases this was incomplete and unclear. However,
more recent studies tended to rate more highly, possibly a
reflection of the increased reporting standards now required by
journals. Although the majority of studies used a non-traditional
design and conducted records review or structured patient
interview, they were on the whole methodologically rigorous. Nine
of the 25 studies provided strong evidence and a further nine
moderate evidence. Only seven studies were graded as insufficient.
Delay intervals
The majority of included studies reported length of delay, and
although more than half obtained these data from abstraction of
hospital records, there was no uniform approach to the provision
of this information. Consequently, it was not possible to determine
definitive delay intervals. Nonetheless, the available data do
demonstrate extreme delay in both the patient and practitioner
phases. What is also clear is that delay intervals are not decreasing;
those recorded in the last 5 years are as lengthy as those recorded
20 years ago. Despite this, we identified no intervention studies
related to upper GI cancers.
Symptom recognition
The results of this review suggest that what is important in terms
of patient delay is recognition of the seriousness of a symptom,
and not simply recognition of the presence of the symptom itself.
Patients who have significant symptoms, and perceive them to be
so, may present promptly. Equally, they may delay through fear.
The catalyst for presentation was often when a symptom became
debilitating or hampered normal activities, but the precise
influence of this was unclear. Experiencing pain, for example,
was found to both reduce and increase patient delay. An obvious
difficulty, particularly with GI cancers, is that common symptoms
can be attributable to benign disease. Consequently, patients may
not present immediately. This poses a challenge for health
educators, who must strike a balance between emphasising the
potentially significant nature of symptoms, regardless of their
commonality, and creating unnecessary fear.
Similarly, symptom recognition and interpretation were no less
important for practitioners. Delays following initial patient
presentation were often the result of misdiagnosis of benign
disease or of adopting a wait and see approach following the first
encounter with the patient.
Patient history
As could perhaps be predicted, patients’ previous experience
played a role in current decisions to consult with cancer
symptoms. Perceptions of symptom seriousness were often based
on a personal or family history of similar symptoms and this could
have a two-fold effect. Such knowledge prompted some patients to
present sooner rather than later; however, for some, the fear that
symptoms were indicative of cancer resulted in delayed consulta-
tion. Patients who redefined their symptoms, perhaps in relation to
that fear or on the basis of prior experience, delayed longer.
Similarly, patients who had previously been treated for benign
disease delayed longer. Conversely, patients with comorbidity
presented more quickly, possibly as a consequence of regular
attendance for other conditions, and the resultant ease with which
new symptoms could be discussed.
In addition, patient history was a significant factor in relation to
practitioner behaviour. Although research relating to the impact of
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coexisting disease or frequent patient attendance was inconclusive,
referral was more likely to be delayed if the patient was being
treated for a benign condition. Delays were also demonstrated
where patients had already been investigated for the same or
similar symptoms and had previous negative test results. Whilst it
is undoubtedly appropriate for practitioners to consider past
history when considering new symptoms or diagnoses, this does
raise the question of when a negative test result should be
considered to be no longer of relevance.
Patient characteristics
The potential for individual patient characteristics to impact on
delay was considered, to some extent, in the included studies, and
analysis of these suggests that lower socio-economic status
increases delay, whereas sex has no impact. However, there
remains a dearth of evidence relating to why some patients
respond to early warning signs or unusual symptoms, whilst,
others do not. Accordingly, there is a prevailing need to
understand the impact of social and psychological factors on
patient behaviour. Many studies focused on the appropriateness of
patient response to symptoms, yet only a minority attempted to
explore the reasons for this, and then primarily from a
psychological perspective. Few have done so from a social
perspective. As a consequence, there is little conclusive evidence
relating to the influence brought to bear by age, level of education
or social network. Yet if we consider that new symptoms occur, not
in isolation, but in the context of an individual’s life circumstances,
Table 3 Practitioner-associated delay factors
Author(s) Location Study type Participants Cancer site
Factors that increase
delay
Factors that decrease
delay
No impact
on delay
Strength of
evidence
Bedikan et al (1979) Texas, USA Retrospective
observational
73 patients (aged o40; 48%
men, 52% women)
Stomach Initial misdiagnosis Moderate
Nagao and Takahashi
(1979)
Japan Retrospective
observational
536 patients Stomach Initial misdiagnosis Insufficient
MacAdam (1979) England Prospective
observational
150 patients (21% with
stomach cancer), 105 GPs
Stomach Cancer site – stomach Regular
consulting rate
of patient
Moderate
Ojala et al (1982) Finland Retrospective
observational
162 patients (aged 38 – 82,
mean 63; 59% men, 41%
women)
Oesophagus Initial misdiagnosis Insufficient
Mikulin and Hardcastle
(1987)
England Prospective
observational
83 patients (mean 71; 64%
men, 36% women)
Stomach Acid suppression
treatment; patient age –
younger
Patient age – older; patient
social class – lower
Moderate
Zilling et al (1990) Sweden Prospective
observational
50 patients (aged 31 – 85,
mean 68; 74% men, 26%
women)
Stomach Patient sex – female;
comorbidity; previously
negative results
Patient sex – male Strong
Hallissey et al (1990) England Cohort 2585 patients with dyspepsia
(aged 40+)
Stomach Initial misdiagnosis Insufficient
Haugstvedt et al
(1991)
Norway Prospective
observational
1165 patients Stomach Patient sex – female Referral to university
hospital
Moderate
Maglinte et al (1991) Indiana, USA Prospective
observational
77 patients (aged 30 – 89,
mean 59; 64% men, 36%
women
Small intestine Inappropriate tests Moderate
Jones and Dudgeon
(1992)
England Retrospective
observational
245 GPs, 1465 patients
(460 with upper GI cancer)
Oesophagus,
stomach
Cancer site – oesophagus Moderate
Arvanitakis et al
(1992)
Greece Observational 100 patients (aged 40 – 90;
64% men, 36% women)
Stomach Initial misdiagnosis Insufficient
Wile et al (1993) California,
USA
Retrospective
observational
49 patients (median 57; 45%
men, 55% women)
Stomach Inaccurate tests Strong
Martin et al (1997) England Prospective
observational
115 patients (aged 31 – 89,
median 66; 61% men, 39%
women)
Oesophagus,
stomach
Frequent attendance by
patient; cancer site –
oesophagus
Access to rapid screening
(open access endoscopy)
Initial symptom Insufficient
Rothwell et al (1997) Ireland Prospective
observational
100 patients (aged 37 – 83,
median 69; 70% men, 30%
women)
Oesophagus Acid suppression
treatment; initial
misdiagnosis; inappropriate
tests
Moderate
Bramble et al (2000) England Retrospective
observational
133 patients (aged 38 – 97,
mean 69; 53% men, 47%
women)
Oesophagus,
stomach
Acid suppression
treatment
Strong
Mariscal et al (2001) Spain Prospective
observational
217 patients (aged 59 – 74,
mean 65; 59% men, 41%
women), 27% with upper GI
cancer
Oesophagus,
stomach
Comorbidity; symptom
type – pain, bleeding
Strong
Irving et al (2002) England Observational 90 patients (72% with
oesophageal, 28% with
gastric)
Oesophagus,
stomach
Use of referral guidelines;
2-week rule
Strong
Manes et al (2002) Italy Cross-sectional 706 endoscopy referrals
(aged 15 – 86, mean 47; 55%
men, 45% women)
Stomach Inappropriate use of
endoscopya
Strong
Look et al (2003) Singapore Retrospective
observational
44 patients (aged 36 – 83,
mean 67; 70% men, 30%
women)
Stomach Previously negative results Moderate
Abbreviation: GI¼ gastrointestinal. aStudy infers findings.
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it is likely that investigations of social factors will yield valuable
insights in this area.
Although only a limited number of patient characteristics were
considered in relation to practitioner referral behaviour, there was
some evidence to suggest that younger and female patients
experienced increased delays. Conversely, patients from lower
socio-economic groups were less likely to experience delay. This is
in direct contrast to the impact of socio-economic status on patient
delay, and it could be postulated that as these patients have already
delayed prior to their initial presentation, the need for rapid
referral is all the more apparent.
Health-care factors
Several recent policy initiatives have been directed at the
practitioner phase of delay, and the results of this review suggests
that these may be starting to have an impact. An evaluation of
outcomes related to the introduction of standardised referral
guidelines in the UK demonstrated positive effects on delay.
Similarly, a relationship between provision of services and reduced
delay has also been shown, with those patients who have use of a
rapid access endoscopy service experiencing less delay in referral.
However, the evidence in this regard is as yet inconclusive, and it
had been suggested that inappropriate use of such a service could
increase delay as a consequence of an increased volume of
referrals. As yet, only a few studies have explored these initiatives
in detail, and although those that have done so indicate that they
are, for the most part, successful, further work will enable more
definitive conclusions to be drawn.
Implications for practitioners
Many of the studies in this review reported practitioner
misdiagnosis as a significant contributor to delay. The studies
were not designed in a way that would allow the observer to assess
the nature of that ‘misdiagnosis’. However, it is clear that there are
significant challenges for practitioners in assessing symptoms such
as dyspepsia, including evaluation in the context of acid
suppression therapy, and previous negative test results. Such
issues need to be clearly addressed within guidelines.
Implications for research
One of the most surprising findings of this review is that although
the majority of studies reported on primary care practitioner
delay, only two of these involved primary care practitioners as
participants and only three recruited patients from primary care.
Most were conducted in secondary care and consisted of a series of
either prospective or retrospective clinic experiences. Further-
more, in those studies involving practitioners, the participants
were primary care doctors. Consequently, the contribution that
may be made by other health-care practitioners, such as nurses,
has not yet been investigated.
Ramirez et al (1999), in their review of factors predicting
delayed presentation with breast cancer, highlighted the need for
further research into understanding delay in order to impact on
presentation behaviour. Although some work has been commis-
sioned since their call for it, it is clear that we still lack
understanding of this area. This review demonstrates the complex
nature of delay and consequently, the difficulty of devising
strategies to reduce it. However, this must be achieved if the
ultimate aim of improving survival is to be met. Influencing this is
likely to involve gaining greater appreciation of the impact of
patient characteristics, alongside development of strategies to aid
practitioners in assessing GI symptoms.
ACKNOWLEDGEMENTS
We acknowledge the support of Michere Beaumont, Catherine
McNeill (Research Secretaries), Jane Goodfellow (Dissemination
and Information Officer) and Madeline Young (Subject Librarian),
University of Glasgow in carrying out this project. We would also
thank David Mant for his input into this project, Joan Austoker
(University of Oxford) for help in identifying international
contacts and Jolanta Astle, Simon Browne, Yulia Gaidakova, Karen
Kane, Marina Novikova, Gaby Vojt and Phil Wilson for translation
of non-English language articles. Finally, we would thank the
authors, cancer leads and other contacts who responded to our
request for relevant work. This study was funded by the UK DoH
(project reference 1217522).
REFERENCES
Arvanitakis C, Nikopoulos A, Giannoulis E, Theoharidis A, Georgilas V,
Fotiou H (1992) The impact of early or late diagnosis on patient survival
in gastric cancer in Greece. Hepato-Gastroenterology 39: 355 – 357
Bedikan AY, Khankhanian N, Helibrun LK, Bodey GP, Stroehlein JR,
Valdivieso M (1979) Gastric carcinoma in young adults. Southern Med J
72(6): 654 – 656
Bramble MG, Suvakovic Z, Hungin APS (2000) Detection of upper
gastrointestinal cancer in patients taking antisecretory therapy prior to
diagnosis. Gut 46(4): 464 – 467
Delaney BC (1998) Why do dyspeptic patients over the age of 50 consult
their general practitioner? A qualitative investigation of health beliefs
relating to dyspepsia. Br J Gen Pract 48: 1481 – 1485
Department of Health (2000) Referral Guidelines for Suspected Cancer.
London: DoH
Grannell MS, Kelly S, Shannon S, Chong AL, Walsh TN (2001) The sinister
significance of dysphagia. Irish J Med Sci 170(4): 244 – 245
Gullo L, Tomassetti P, Migliori M Casadei R, Marrano R (2001) Do early
symptoms of pancreatic cancer exist that can allow for an earlier
diagnosis? Pancreas 22(2): 210 – 213
Hackett TP, Cassem NH, Raker JN (1973) Patient delay in cancer. New Engl
J Med 289(1): 14 – 20
Hallissey MT, Allum WH, Jewkes AJ, Ellis DJ, Fielding JWL (1990) Early
detection of gastric cancer. BMJ 301: 513 – 515
Haugstvedt TK, Viste A, Eide GE, Soreide O (1991) Patient and physician
treatment delay in patients with stomach cancer in Norway: is it
important? Scand J Gastroenterol 26(6): 611 – 619
Ibingira CBR (2001) Management of cancer of the stomach in Mulago
hospital, Kampala, Uganda. East Afr Med J 78(5): 233 – 237
Irving MJ, Lamb PJ, Irving RJ, Raimes SA (2002) Speeding up the diagnosis
of oesophago-gastric cancer. Nurs Times 98(51): 35 – 37
Jones RVH, Dudgeon TA (1992) Time between presentation and treatment
of 6 common cancers: a study in Devon. Br J Gen Pract 42: 419 – 422
Look M, Tan YY, Vijayan A, Teh CH, Low CH (2003) Management delays
for early gastric cancer in a country without mass screening. Hepato-
Gastroenterology 50: 873 – 876
Love N (1991) Why patients delay seeking care for cancer symptoms. What
you can do about it. Postgrad Med 89: 151 – 158
MacAdam DB (1979) A study in general practice of the symptoms and delay
patterns in the diagnosis of gastrointestinal cancer. J R College Gen Pract
29: 723 – 729
Macdonald S, Macleod U, Mitchell E, Weller D, Campbell N, Mant D (2004)
Factors influencing patient and primary care delay in the diagnosis of
cancer: a database of existing research and its implications for future
practice. Final report to the UK Department of Health Glasgow:
University of Glasgow
Maglinte DDT, O’Connor K, Besette J, Chernish SM, Kelvin FM (1991) The
role of the physician in the late diagnosis of primary malignant tumours
of the small intestine. Am J Gastroenterol 86(3): 304 – 308
Manes G, Balzano A, Marone P, Lionello M, Mosca S (2002) Appropriate-
ness and diagnostic yield of upper gastrointestinal endoscopy in an open
access endoscopy system: a prospective observational study based on the
Maastricht guidelines. Alimentary Pharmacol Therapeut 16: 105 – 110
Delay in diagnosis of upper GI cancers
S Macdonald et al
1278
British Journal of Cancer (2006) 94(9), 1272 – 1280 & 2006 Cancer Research UK
C
lin
ic
a
l
S
tu
d
ie
s
Mariscal M, Llorca J, Prietd D, Delgado-Rodriguez M (2001) Determinants
of the interval between the onset of symptoms and diagnosis in patients
with digestive tract cancers. Cancer Detect Prevent 25(5): 420 – 429
Martin IG, Young S, Sue-Ling H, Johnson D (1997) Delays in the
diagnosis of oesophagastric cancer: a consecutive case series. BMJ 314:
467 – 470
Mikulin T, Hardcastle JD (1987) Gastric cancer – delay in diagnosis and its
causes. Eur J CancerClin Oncol 23(11): 1683 – 1690
Mitchell E, Sullivan F (2001) A descriptive feast but an evaluative famine:
systematic review of published articles on primary care computing
during 1980 – 97. BMJ 322: 79 – 82
Nagao F, Takahashi N (1979) Diagnosis of advanced gastric cancer. World J
Surg 3: 693 – 700
National Institute for Health and Clinical Excellence (2005) Referral
Guidelines for Suspected Cancer: Clinical Guideline 27. London: NICE
Nichols S, Waters WE, Fraser JD, Wheeller MJ, Ingham SK (1981) Delay in
the presentation of breast symptoms for consultant investigation.
Commun Med 3: 217 – 225
Ojala K, Sorri M, Jokinen K, Kariluoma M (1982) Symptoms of carcinoma
of the oesophagus. Med J Austr 1(9): 384 – 385
Pack GT, Gallo JS (1938) The culpability for delay in the treatment of
cancer. Am J Cancer 33: 443 – 462
Ponten J, Adami HQ, Bergstrom R, Dilner J, Friberg LG, Gustafsson L,
Miller AB, Parkin DM, Sparen P, Trichopoulos D (1995) Strategies for
global control of cervical cancer. Int J Cancer 60(1): 1 – 26
Porta M, Gallen M, Belloc J, Malats N (1996) Predictors of the interval
between the onset of symptoms and first medical visit in patients with
digestive tract cancer. Int J Oncol 8: 941 – 949
Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards
MA (1999) Factors predicting delayed presentation of symptomatic
breast cancer: a systematic review. Lancet 353: 1127 – 1131
Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ (1999)
Influence of delay on survival in patients with breast cancer: a systematic
review. Lancet 353: 1119 – 1126
Rothwell JF, Feehan E, Reid I, Walsh TN, Hennessy TPJ (1997) Delay in
treatment for oesophageal cancer. Br J Surg 84(5): 690 – 693
Summerton N (1999) Diagnosing Cancer in Primary Care. Oxford: Radcliffe
Medical Press
Wile AG, Hourani L, Schell MJ (1993) The contribution of patient factors,
physician delay and tumour biology to the outcome of gastric cancer. Am
Surgeon 59(12): 850 – 854
Zilling TL, Walther BS, Ahren B (1990) Delay in diagnosis of gastric cancer:
a prospective study evaluating doctors’ and patients’ delay and its
influence on five year survival. Anticancer Res 10: 411 – 416
Appendix A1
Scoring system – experimental studies
(Randomised controlled trials/case-controlled trials/controlled
before and after studies)
Notes
Sample formation
2 – Random K For example, stratification
1 – Quasi random K Randomised by toss of coin – 1
K Group members acting as both intervention and control
(if randomised) – 1
0 – Selected, concurrent or historical K Subjects chosen
Baseline differences
2 – None or adjusted
1 – Differences unadjusted Mentioned but not specified (e.g. no difference) – 1
0 – No statement
N.B. This is the difference between groups providing the unit of analysis
Unit of allocation
2 – Practice/clinic
1 – Doctor Nothing of note
0 – Patient
Outcome measures
2 – Objective/subjective with assessors blinded
1 – Subjective, assessors not blinded, explicit criteria given K Questionnaires – 1
K Mentions ‘eligible’ patients but does not specify what eligible is (open to
interpretation) - 1 (or based on scores etc.)
K Mentions that outcomes may be under/over estimated
0 – Subjective, assessors not blinded, no explicit criteria
Follow-up
2 – 490% subjects starting study K Is information provided to verify that researchers know that all subjects
were contacted
1 – 80–90% subjects starting study Exclude from follow-up calculation:
K Subjects excluded from analysis
0 – o80% subjects starting study K Non-responders in questionnaire surveys
K If there is no statement about follow-up or conclusive information in tables
(e.g. baseline n ¼ ...; follow-up n¼y) do not calculate. Follow-up ¼
unable to determine
N.B. This relates to subjects accounted for at the end of the study, not just
those with a positive outcome.
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Appendix B1
Scoring system – descriptive studies
Source of case
Duration/intensity
of exposure
Validity of
measures Quality control
Subject ‘compliance’
rate
Postintervention
data
Case report
1 – Identified 1 – Information 1 – Statement 1 – Statement 1 – Information 1 – Given
0 – Not identified 0 – No information 0 – No statement 0 – No statement 0 – No information 0 – Not given
Source of cases Inclusion/exclusion
criteria
Sampling method Duration/intensity
of exposure
Validity of measures Subjects lost to
follow-up
Case series
1 – Identified 1 – Statement 1 – Given 1 – Information 1 – Statement 1 – Information
0 – Not identified 0 – No statement 0 – Not given 0 – No information 0 – No statement 0 – No information
Research Q or
hypothesis
Source of cases Inclusion/
exclusion criteria
Sample size Dealing with bias or
confounders
Analytic methods
Cross-sectional study
1 – Statement 1 – Identified 1 – Statement 1 – Statement 1 – Information 1 – Description
0 – No statement 0 – Not identified 0 – No statement 0 – No statement 0 – No information 0 – No description
Research Q or
hypothesis
Source of cases Inclusion/
exclusion criteria
Nonresponse rate Starting point for each
subject
Duration/intensity
of exposure
Cohort study
1 – Statement 1 – Identified 1 – Statement 1 – Statement 1 – Definition 1 – Information
0 – No statement 0 – Not identified 0 – No statement 0 – No statement 0 – No definition 0 – No information
Research Q or
hypothesis
Source of cases Source of controls Inclusion/exclusion
criteria
Sampling method Comparability of
control group
Case– control study
1 – Statement 1 – Identified 1 – Identified 1 – Statement 1 – Given 1 – Statement
0 – No statement 0 – Not identified 0 – Not identified 0 – No statement 0 – Not given 0 – No statement
Research Q or
hypothesis
Source of cases Inclusion/
exclusion criteria
Sample size Starting point for each
subject
Validity of
measures
Before and after study
1 – Statement 1 – Identified 1 – Statement 1 – Statement 1 – Definition 1 – Statement
0 – No statement 0 – Not identified 0 – No statement 0 – No statement 0 – No definition 0 – No statement
K If simply states‘ to
evaluate’ ¼ 0
K For patients - disease K Explicit statement,
or face validity
K For GPs starting point;
background; where
evaluation is coming
from
(comparison to ‘gold
standard’ would be
ideal, but we accepted
less in these designs)
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